Injectable Naltrexone For Alcohol Dependence
Naltrexone generic for extended-release in-jectable suspension (Vivitrol, Alkermes/ Cephalon) has been approved for the treatment of alcohol dependence.
This once-monthly injectable medication is indicated for alcohol-dependent patients who are able to abstain from drinking in an outpatient setting and who are not actively drinking when they begin treatment. This agent should be used in combination with psychosocial support.
Vivitrol will be available as a single-dose 380-mg IM injection by the end of June.
